gabapentin immediate-release (capsules, tablets, oral solution) — CareFirst (Caremark)
Management of postherpetic neuralgia in adults
Initial criteria
- Authorization may be granted when the patient is NOT taking more than 3600 mg per day of gabapentin.
Approval duration
12 months